¼¼°èÀÇ Æ¯¼ö ÀǾàǰ ½ÃÀå(2025-2029³â)
Global Specialty Pharmaceuticals Market 2025-2029
»óǰÄÚµå : 1792202
¸®¼­Ä¡»ç : TechNavio
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 229 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,500 £Ü 3,512,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,000 £Ü 5,619,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Ư¼ö ÀǾàǰ ½ÃÀåÀº 2024-2029³â¿¡ 5,031¾ï ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø±â°£ Áß CAGRÀº 14.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Ư¼ö ÀǾàǰ ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¡¤¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» °ÔÀçÇϰí ÀÖ½À´Ï´Ù.

ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. Á¤ºÎÀÇ ÇコÄɾî ÁöÃâ·Î ÀÎÇÑ ¿¬±¸°³¹ß ¼ö¿ä Áõ°¡, Ư¼ö ÀǾàǰ ¿¬±¸°³¹ßºñ¿ë Àý°¨ÀÇ Çʿ伺, º¹ÀâÇÑ Áúº´°ú ±× ¿¹¹æ¿¡ ´ëÇÑ ÀνÄÀ» È®»êÇϱâ À§ÇÑ Á¤ºÎ ¹× ´Ù¾çÇÑ ºñ¿µ¸® ´ÜüÀÇ ³ë·Â µîÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁØ¿¬µµ 2025
Á¾·á¿¬µµ 2029
¿¹Ãø ±â°£ 2025-2029
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³â´ëºñ 12.5%
CAGR 14.8%
Áõ°¡¾× 5,031¾ï ´Þ·¯

º» Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü¿©ÀÚµéÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ Á¤º¸¿Í 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î Á¶ÇÕÇÏ¿© ½Ç½ÃµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼­¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®°ú ÇÔ²² Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ª ºÐ¼®¿¡ µû¸¥ ¼¼ºÐÈ­, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼­¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.

º» Á¶»ç¿¡¼­´Â ÇâÈÄ ¼ö³â°£ Àü¹®ÀǾàǰ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î ³ëÀÎ Àα¸ Áõ°¡¸¦ ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ Á¦Á¶¾÷üÀÇ Àü¹®ÀǾàǰ¿¡ ´ëÇÑ ¿¬±¸°³¹ß ÅõÀÚ Áõ°¡, ¹ÙÀÌ¿ÀÀǾàǰ »ê¾÷¿¡ ´ëÇÑ ÅõÀÚ ¹× °³¹ß Áõ°¡´Â ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Technavio ºÐ¼®

Á¦3Àå ½ÃÀå ±¸µµ

Á¦4Àå ½ÃÀå ±Ô¸ð

Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû

Á¦6Àå Á¤¼º ºÐ¼®

Á¦7Àå Five Forces ºÐ¼®

Á¦8Àå ½ÃÀå ¼¼ºÐÈ­ : ¿ëµµº°

Á¦9Àå ½ÃÀå ¼¼ºÐÈ­ : À¯Åë ä³Îº°

Á¦10Àå ½ÃÀå ¼¼ºÐÈ­ : Åõ¿© °æ·Îº°

Á¦11Àå °í°´ »óȲ

Á¦12Àå Áö¿ªº° »óȲ

Á¦13Àå ÃËÁø¿äÀΡ¤°úÁ¦¡¤±âȸ¡¤¾ïÁ¦¿äÀÎ

Á¦14Àå °æÀï ±¸µµ

Á¦15Àå °æÀï ºÐ¼®

Á¦16Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The specialty pharmaceuticals market is forecasted to grow by USD 503.1 bn during 2024-2029, accelerating at a CAGR of 14.8% during the forecast period. The report on the specialty pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for research and development due to government healthcare expenditure, need for cost-cutting in specialty pharmaceutical discovery and development, and initiatives by government and various non-profit organizations to spread awareness of complex diseases and their prevention.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 202512.5%
CAGR14.8%
Incremental Value$503.1 bn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's specialty pharmaceuticals market is segmented as below:

By Application

By Distribution Channel

By Route Of Administration

By Geographical Landscape

This study identifies the increasing geriatric population as one of the prime reasons driving the specialty pharmaceuticals market growth during the next few years. Also, increase in research and development investments in specialty pharmaceuticals by manufacturers and rising investments and developments in biopharmaceutical industry will lead to sizable demand in the market.

The report on the specialty pharmaceuticals market covers the following areas:

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading specialty pharmaceuticals market vendors that include AbbVie Inc., Amgen Inc., Bristol Myers Squibb Co., CVS Health Corp., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Humana Inc., Hyphens Pharma Pte Ltd., Johnson and Johnson Services Inc., McKesson Corp., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Supernus Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., The Cigna Group, United Health Group Inc., and Viatris Inc.. Also, the specialty pharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Application

9 Market Segmentation by Distribution Channel

10 Market Segmentation by Route of Administration

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â